GlassScriptPhysician profile
Herman W Parramore
NPI 1255325122
$5,465.39
in general payments reported to CMS, 2019-2025
45 companies · $1,034 in 2025
The $1,034 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $955 · 2020: $385 · 2021: $661 · 2022: $947 · 2023: $809 · 2024: $675 · 2025: $1,034.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,230 · Travel and Lodging: $287.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,230.21 |
| Travel and Lodging | $287.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $653.85 | 2019-2024 | Erleada |
| Astellas Pharma US INC | $649.10 | 2019-2023 | Myrbetriq |
| Abbvie INC. | $484.82 | 2019-2025 | |
| Coloplast Corp | $430.01 | 2019-2025 | Speedicath |
| Procept Biorobotics Corporation | $387.87 | 2024-2025 | Aquabeam System |
| Endo Pharmaceuticals INC. | $259.37 | 2019-2024 | Xiaflex, Aveed |
| Boston Scientific Corporation | $215.70 | 2020-2025 | Ams 700, Spaceoar Vue System - 10ml, Advantage System |
| Neotract INC. | $208.94 | 2019 | |
| Allergan, INC. | $193.61 | 2019-2022 | |
| Sumitomo Pharma America, INC. | $162.23 | 2023-2025 | Gemtesa, Orgovyx |
| Antares Pharma, INC. | $145.31 | 2020-2025 | Xyosted, Nocdurna, Tlando |
| Olympus America INC. | $132.55 | 2023-2025 | Itind System |
| Rochester Medical Corporation | $122.31 | 2021-2022 | |
| Teleflex LLC | $99.79 | 2023-2025 | Urolift, Barrigel |
| 180 Medical, INC. | $85.00 | 2019-2024 | Gentlecath Glide |
Show all 45 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $84.34 | 2020-2022 | |
| Urogen Pharma, INC. | $70.24 | 2022-2025 | |
| Pfizer INC. | $68.52 | 2019-2025 | |
| Urovant Sciences INC | $64.00 | 2021-2022 | |
| Medtronic, INC. | $63.35 | 2021-2025 | Interstim |
| Axonics, INC. | $62.30 | 2023-2024 | Axonics, Bulkamid |
| Astrazeneca Pharmaceuticals LP | $59.91 | 2020-2025 | Farxiga |
| Lemaitre Vascular, INC. | $52.49 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $50.43 | 2025 | Xifaxan |
| Phathom Pharmaceuticals, INC. | $46.88 | 2024-2025 | Voquezna |
| Laborie Medical Technologies Corp. | $46.56 | 2023-2025 | Optilume Bph Drug Coated Balloon Catheter |
| Cook Medical LLC | $45.83 | 2020-2025 | Cook |
| Ambu INC. | $45.77 | 2021-2024 | |
| Hollister Incorporated | $43.90 | 2020-2023 | Infyna Chic, Vapro, Vapro Pocket |
| Ferring Pharmaceuticals INC. | $41.28 | 2024-2025 | Adstiladrin |
| Bayer Healthcare Pharmaceuticals INC. | $40.60 | 2019-2020 | |
| Endo USA, INC. | $39.61 | 2024-2025 | Xiaflex, Aveed |
| Osiris Therapeutics INC. | $38.83 | 2019 | |
| Blue Earth Diagnostics | $37.64 | 2021-2023 | |
| Smith+Nephew, INC. | $35.95 | 2019 | |
| Lilly USA, LLC | $29.37 | 2023-2024 | Mounjaro |
| Becton, Dickinson and Company | $24.25 | 2024 | |
| Vanda Pharmaceuticals INC. | $23.49 | 2024 | Fanapt, Hetlioz |
| Myovant Sciences INC. | $21.87 | 2022 | |
| Calyxo, INC. | $21.22 | 2025 | Cvac Aspiration System |
| Davol INC. | $17.13 | 2025 | |
| Novo Nordisk INC | $16.76 | 2023 | Wegovy |
| Amgen INC. | $14.98 | 2020 | |
| Halozyme INC | $13.79 | 2023 | |
| Baudax Bio INC. | $13.64 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Herman Parramore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.